12th World Meeting
on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
11 - 14 May 2021 | Online Conference

The Austria Center Vienna has informed us today that the local government has built up a SARS-CoV-2 test center in the congress halls, where we had planned to hold our 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology on May 11-14, 2021. 

Due to the current uncertain sanitary situation and limited travel options during the pandemic, the organisers decided to completely hold the PBP World Meeting and its accompanying exhibition ResearchPharm® as a virtual event on the same days. 

The deadline for abstract submission is postponed to 31 January 2021. 

More detailed information, e.g. on the updated registration fees, existing and new conference registrations, minor changes to the scientific programme, and technical details will follow soon. 

We do hope that you may understand our decision. We promise to go to the beautiful city of Vienna with one of our future PBP World Meetings. 

The presidents of ADRITELF, APGI and APV are looking forward to welcoming you to our online conference and exhibition in May. Stay tuned and healthy!

We would like to thank our sponsors

PLATINUM SPONSORS

GOLD SPONSORS

SILVER SPONSORS
 
 

COPPER SPONSORS

Our organisations

Participating societies

ADRITELF
APGI
APV
APPIE (The Association of Powder Process Industry and Engineering, JAPAN)
APS
Arbeitskreis Prozessanalytik
EASP (Estonian Academical Society of Pharmacy)
Finnish Pharmaceutical Society
Geriatric Medicines Society
GSIA
HFD (Croatian Pharmaceutical Society)
HSPS (Hungarian Society for Pharmaceutical Sciences)
Italian Chemical Society
Malta Pharmaceutical Association
Austrian Pharmaceutical Society (ÖPhG)
PTFarm (Polish Pharmaceutical Society)
SEFIG
SFD (Slovenian Pharmaceutical Society)
SFUS (Pharmaceutical Association of Serbia)
Swiss Biotech Association

Media Partners

Biomedicines
Crystals
European Biopharmaceutical Review
Manufacturing Technology Insights
Pharmaceutics
Pharma Tech Outlook